Form 8-K - Current report:
SEC Accession No. 0000950123-05-002776
Filing Date
2005-03-08
Accepted
2005-03-08 17:21:11
Documents
2
Period of Report
2005-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y06318e8vk.txt 8-K 4763
2 SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENT y06318exv10w1.txt EX-10.1 17168
  Complete submission text file 0000950123-05-002776.txt   23866
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 05667467
SIC: 2835 In Vitro & In Vivo Diagnostic Substances